Program Information

January - March: This activity meets on the 4th Tuesday of the month from 1-2pm ET.

April - December: This activity meets on the 3rd Tuesday of the month from 1-2pm ET.

This program provides front-line primary care clinicians and team members with the support and expert advice they need to gain confidence in treating substance use disorders with an integrated care approach. Topics covered in the series include medications for the treatment of opioid use disorder (e.g., methadone, buprenorphine, and naltrexone) and alcohol use disorder, polysubstance use, xylazine and other adulterants, toxicology screening and interpretation, trauma-informed care, harm reduction, motivational interviewing, and care coordination. In addition to didactic presentations on these high-value topics, each session also offers participants the opportunity to present real life patient cases and receive recommendations from the expert faculty and their peers in the program. Together, participants and the faculty build a community of practice that strengthens the capacity of primary care medical and behavioral health providers to provide care for patients with substance use disorders.

Target Audience

This activity is appropriate for the following audiences:

Primary care providers (MDs, DOs, NPs, PAs)
Behavioral health providers (Psychiatrists, Psychologists, Social Workers, Therapists)
Nurses
Pharmacists
Other members of the care team (Peer Recovery Supporters, Care Coordinators)

Learning Objectives

Related to patents with substance use disorders, by the end of this series, participants will be able to:

Integrate medication-assisted treatment and behavioral health interventions to develop comprehensive care strategies for patients with substance use disorders.
Analyze toxicology screening results to inform and tailor individualized treatment plans.
Apply harm reduction strategies and motivational interviewing techniques to effectively engage and support patients in their recovery.
Collaborate within a multidisciplinary team to coordinate care and enhance patient outcomes, with a focus on underserved communities.

AMA Designation Statement

Moses/Weitzman Health System Inc. designates this Live activity for a maximum of 12 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity summary

Available credit:

12.00 AAPA Category I CME
Through Joint Accreditation, Moses/Weitzman Health Center, Inc./Weitzman Institute is able to provide American Academy of PAs (AAPA) credit to physician assistants at its activities. Participants should only claim commensurate credit with the extent of their participation in the activity.
12.00 ACE/ASWB
Through Joint Accreditation Moses/Weitzman Health Center, Inc./Weitzman Institute is able to provide Association of Social Work Boards (ASWB) credit to social workers at its activities.
12.00 ACPE
Through Joint Accreditation, Moses/Weitzman Health Center, Inc./Weitzman Institute is able to provide Accreditation Council for Pharmacy Education (ACPE) credit to pharmacists at its activities.
12.00 AMA PRA Category 1 Credit™
Through Joint Accreditation, Moses/Weitzman Health Center, Inc./Weitzman Institute is able to provide AMA PRA Category 1 Credit™ to physicians at its activities via Accreditation Council for Continuing Medical Education (ACCME).
12.00 ANCC
Through Joint Accreditation, Moses/Weitzman Health Center, Inc./Weitzman Institute is able to provide American Nurses Credentialing Center (ANCC) nursing credit to nurses at its activities.
12.00 APA
Through Joint Accreditation, Moses/Weitzman Health Center, Inc./Weitzman Institute is able to provide American Psychological Association (APA) credit to psychologists at its activities.
12.00 Participation Hour(s)
You are able to download an unaccredited Participation Certificate for your records if you are not able to use any of the credit types provided for this activity or if this activity does not offer accredited CME/CE credits.

Activity opens:

01/07/2025

Activity expires:

12/31/2025

Schedule

This activity meets the fourth Tuesday of every month from 1-2pm ET. Below are the dates of the sessions:

January 28, 2025
February 25, 2025
March 25, 2025
April 15, 2025
May 20, 2025
June 17, 2025
July 15, 2025
August 19, 2025
September 16, 2025
October 21, 2025
November 18, 2025
December 16, 2025

Faculty

Marwan Haddad, MD, MHP, AAHIVS

Daniel Bryant, LPC

Michelle Geier, PharmD, BCPP, APH

Briana Reaves, MBA

Jeannie McIntosh, APRN, FNP-C, AAHIVS

Mikveh Warshaw, RN, PMHMP, CARN-AP

Richard Feuer, MD

Weitzman Institute Disclosure Statement

It is the policy of the Weitzman Institute to ensure that Continuing Education (CE) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the Weitzman Institute requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

Faculty participating in a Weitzman Institute-sponsored activity must disclose to the planning committee and audience all financial or other relationship(s) with ineligible companies.